Where does Creo Medical Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Creo Medical Limited ranks #3,728 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Creo Medical Limited hold?

Creo Medical Limited holds 97 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Creo Medical Limited's Innovation Score?

Creo Medical Limited has an Innovation Score of 53.9 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Creo Medical Limited focus on?

Creo Medical Limited's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 93 patents. Grants appear in 18 CPC subclasses total.

Is Creo Medical Limited's patent grant rate increasing or decreasing?

Creo Medical Limited's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Creo Medical Limited's patents?

Creo Medical Limited's patents average 18.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Creo Medical Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Creo Medical Limited

USPTO PatentsView assignee record - 97 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Creo ranks #3,728 of 49,997 tracked US assignees by granted-patent volume, with 97 patents across 18 technology areas.

#3,728
of 49,997 US assignees by volume: Top 8%
by Innovation Score (53.9/100): 18.3
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3728 · Foreign Corporation #3,728 · 97 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 97 grants
TOP-DECILE #3,728/49,997
PHOTO-FINISH Arizona Board of…
CPC-FOCUS A61B · 18 areas
INNOV-PAR 53.9/100
CLAIMS-RICH 18.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arizona Board of Regents on Behalf of Northern Arizona University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
CalAmp · near

54
Creo Medical · this assignee

54
Hisense USA · near

54
Pentair Water Pool… · near

54
Chang Gung University · near

54
3D Lighting… · lowest

7

What this shows Creo's Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Creo's grants concentrate

Creo Medical Limited is a focused PatentsView assignee: 18 CPC subclasses with 95.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (18 grants) versus a trough of 3 in 2017. By volume, Creo sits between Arizona Board of Regents on Behalf of Northern Arizona University and Dynasty Footwear, Ltd..

Creo's three-year grant acceleration

From 2019–2021 to 2022–2024, Creo Medical Limited moved from 26 to 47 grants (1.81x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Arizona Board of…

97
Arlo

97
Bulgari S P A

97
Berlin Packaging

97
Carefusion 2200

97
Dongguan Jiasheng…

97
DSP Group

97
Dynasty Footwear

97
Creo Medical ◀

97

What this shows Creo holds 97 patents at rank #3,727, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Creo

By rank, the assignees closest to #3,727 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Creo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Creo, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Pentair Water Pool and Spa, Inc. 54 CalAmp Corp 54 Hisense USA Corporation 54 Chang Gung University 54

Similar claim depth

Nearest assignees by average claims per patent (18.3 here).

Imperial College Innovations Ltd 18.3 avg Space Exploration Technologies Corp. 18.3 avg Banner Engineering Corp. 18.3 avg Ndsu Research Foundation 18.3 avg

Creo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Creo Medical Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	4.1%
2016	5	5.2%
2017	3	3.1%
2018	3	3.1%
2019	7	7.2%
2020	7	7.2%
2021	12	12.4%
2022	12	12.4%
2023	18	18.6%
2024	17	17.5%
2025partial year	9	9.3%

Which technologies does Creo Medical Limited patent most?

A61B - DIAGNOSIS; SURGERY; Identification 93

H01P - WAVEGUIDES; Resonators, Lines, OR Other Devices OF THE Waveguide Type 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 10

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 8

H01Q - Antennas, i.e. Radio Aerials 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 5

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 4

H03F - Amplifiers 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

H01J - Electric Discharge Tubes OR Discharge Lamps 2

F16C - SHAFTS; Flexible SHAFTS; Elements OR Crankshaft MECHANISMS; Rotary Bodies Other Than Gearing ELEMENTS; Bearings 1

F16H - Gearing 1

G02B - Optical Elements, Systems OR Apparatus 1

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 1

Top 15 of 18 technology areas

Where it ranks

Overall rank by patents

#3,728

of 49,997 tracked assignees

Innovation Score

53.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Creo Medical Limited's patent record in context - here's where to go next.

Creo Medical Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,728 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Creo Medical Limited against Arizona Board of Regents on Behalf of Northern Arizona University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.